Manor Road Capital's Q3 and Q4 13F filings reveal major portfolio changes, with elimination of holdings in Amazon, Facebook, and more.
Ava Hoppe | 20 April, 2023
Manor Road Capital Partners, LLC, a hedge fund that manages approximately $1.3 billion in assets, recently released its third quarter (Q3) and fourth quarter (Q4) 13F filings, revealing their portfolio changes.
The firm's Q4 13F filings showed that they reduced their holdings from Q3, with their shares dropping from 119,200 to 0, and the total value of their assets declining from $52,646,000 to $0. This sudden decrease was partly due to the elimination of some of their major positions, including Liberty Broadband Corporation, Amazon, Facebook, Transdigm Group, NVR Inc, American Tower Corp New, Mastercard Incorporated, and Moodys Corporation.
In Q3 2021, Manor Road Capital held 89,700 shares of Liberty Broadband Corporation (LBRDK) worth $15,491,000, making up 29.45% of their portfolio. In contrast, the fourth quarter filings showed that they completely reduced their holdings in the company, holding zero shares.
Similarly, in Q3 2021, the firm held 3,700 shares of Amazon (AMZN) worth $12,155,000 and 20,000 shares of Facebook (META) worth $12,116,000. However, in Q4 2021, Manor Road Capital completely sold off its shares in both companies, resulting in zero shareholdings for the two tech giants.
The hedge fund held 8,700 shares of Transdigm Group (TDG) worth $5,434,000 in Q3, but this position was also eliminated in Q4. The Q3 reports also showed that the firm had 1,100 shares of NVR Inc (NVR) worth $5,273,000, 19,800 shares of American Tower Corp New (AMT) worth $5,255,000, 11,700 shares of Mastercard Incorporated (MA) worth $4,068,000, and 11,200 shares of Moodys Corporation (MCO) worth $3,977,000. All these positions were also eliminated in Q4.
Despite the elimination of these major positions, Manor Road Capital increased its holdings in other companies such as PTC Therapeutics, which saw an increase in shares from 2,277,900 to 2,692,100. The Q3 13F filings showed that the hedge fund had 1,655,800 shares in LabCorp (LH) worth $366,096,000, and the Q4 filings revealed that the firm increased its stake in the company by 160,100 shares, bringing their total number of shares to 1,815,900.
The filings also showed that in Q3, the firm held 2,703,000 shares in Tri Pointe Homes (TPH) worth $45,648,000, but this position was reduced to 2,514,500 shares worth $47,836,000 in Q4. In addition, the hedge fund added positions in companies like Avis Budget Group, Inc. (CAR), holding 1,018,400 shares worth $125,047,000, and Coinbase Global, Inc. (COIN), with 272,000 shares worth $70,695,000.
Overall, the 13F filings reveal that Manor Road Capital Partners, LLC, made several significant changes to its portfolio. The fund eliminated positions in several well-known companies while adding positions in others. It is evident that the company is continuously monitoring its portfolio and making decisions based on its perceived opportunities for growth and risk management. These filings are critical to keep tabs on, as they offer an insight into the investment strategies and market outlook of various hedge funds and institutional investors.
Other Posts
- Navigating the Waters of Global Private Equity: The Strategic Sale of SMAC Explored
- Peddock Capital Advisors, LLC Q2 2023 vs. Q3 2023 13F Holdings Comparison
- SignalPoint Asset Management's Q4 2022 vs. Q1 2023 Holdings Comparison Reveals Surprising Changes
- Taconic Capital Advisors LP Q3 2022 vs. Q4 2022: Major Changes in Top Holdings
- The Changing Landscape of Peloton Wealth Strategists: Q3 2022 vs. Q4 2022
- Thoma Bravo, L.P. Q3 vs. Q4 2022: Analysis of 13F Holdings Report
- Versor Investments LP Q3 and Q4 2022 13F Holdings Comparison: Notable Changes Made to Holdings
- Unwrapping the Future: A Deep Dive into the Shifts in Investment Strategies in Early 2024
- Orinda Asset Management LLC's Recent Changes in Holdings: RLJ Lodging Trust, Sabra Health Care REIT, STAG Industrial, and More
- The Future of Healthcare Education: Levine Leichtman Capital Partners Sells Therapeutic Research Center